Global Large-Volume Wearable Patch Drug Delivery Devices Supply, Demand and Key Producers, 2026-2032
The global Large-Volume Wearable Patch Drug Delivery Devices market size is expected to reach $ 5921 million by 2032, rising at a market growth of 8.7% CAGR during the forecast period (2026-2032).
In 2025, global sales volume of large-volume wearable patch drug delivery devices was approximately 8.05 million units, with an average price of about US$400 per unit, corresponding to a market size of around US$3.22 billion. A large-volume wearable patch drug delivery device is a sterile, disposable, automated drug delivery system that is preloaded with liquid medication and directly attached to the patient?s skin. It automatically delivers a large dose of drug, typically more than 2 mL and potentially up to 10 mL to 50 mL, into the patient?s body in a controlled, slow, and safe manner through subcutaneous infusion within a defined period, usually ranging from several tens of minutes to several hours. Large-volume wearable drug delivery devices, also known as on-body delivery systems, integrate three core technology modules: miniature power transmission, flexible subcutaneous insertion, and long-duration sterile drug storage. By combining these capabilities, they enable a major shift in drug administration. The technology transforms long-duration, high-dose treatment processes that previously relied on hospital-based intravenous infusion into intelligent, autonomous subcutaneous infusion in the home setting. It has become a key enabling platform for improving patient adherence and reducing healthcare costs in biologics, long-acting GLP-1 drugs, and complex monoclonal antibody therapies.
The growth of large-volume wearable patch drug delivery devices is primarily driven by the structural shift in biologic drug administration. As monoclonal antibodies, fusion proteins, long-acting GLP-1 therapies, and other high-value complex formulations continue to expand, conventional intravenous infusion and short-duration injection formats increasingly face limitations in patient adherence, healthcare resource utilization, and treatment convenience. Large-volume wearable patch delivery devices enable relatively high-volume subcutaneous administration to be performed automatically in home-based settings, creating strong substitution value in chronic disease management, long-term biologic therapy, and frequent treatment scenarios.
On the demand side, the global healthcare system is moving from hospital-centered care toward home-based, outpatient, and patient-managed treatment models. This is the most important long-term driver for the market. For pharmaceutical companies, wearable patch delivery devices are not merely packaging or injection tools; they are strategic platforms for improving drug differentiation, enhancing patient experience, extending product life cycles, and supporting drug-device combination product launches. In particular, the growth of high-viscosity, large-volume, and long-acting formulations is expanding the technical gap that conventional prefilled syringes and autoinjectors cannot fully address, encouraging deeper partnerships between pharmaceutical companies and platform providers such as Enable Injections, West, Ypsomed, BD, Gerresheimer, Stevanato, and Nemera.
On the supply side, the maturation of miniature drive systems, flexible cannula technologies, low-residual fluid paths, sterile drug reservoirs, adhesive systems, and user feedback modules is helping large-volume wearable delivery devices move from concept validation toward commercial-scale adoption. This market is not driven by hardware shipment growth alone. It is closely linked to pharmaceutical pipelines, combination product approvals, supply chain qualification, and patient affordability. As a result, the competitive advantages of leading companies are built around drug-device development experience, quality systems, scalable manufacturing, pharmaceutical customer relationships, and regulatory support capabilities, rather than device cost alone.
Over the next few years, market growth is expected to be supported by three major drivers. First, the continued expansion of biologics and long-acting therapies will create demand for devices capable of handling higher volumes, higher viscosities, and longer delivery durations. Second, healthcare cost containment and hospital capacity pressure will accelerate the shift of selected infusion therapies to home and outpatient settings. Third, patients are increasingly receptive to convenient, less painful, and lower-intervention delivery formats. At the same time, device cost, reliability validation, drug compatibility, regulatory timelines, and pharmaceutical project adoption cycles remain key constraints. Overall, large-volume wearable patch drug delivery devices represent a high-growth but not rapidly commoditized market, where near-term competition will remain led by a limited group of specialized platform companies with mature technologies and strong pharmaceutical partnerships.
This report studies the global Large-Volume Wearable Patch Drug Delivery Devices production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Large-Volume Wearable Patch Drug Delivery Devices and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Large-Volume Wearable Patch Drug Delivery Devices that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Large-Volume Wearable Patch Drug Delivery Devices total production and demand, 2021-2032, (K Units)
Global Large-Volume Wearable Patch Drug Delivery Devices total production value, 2021-2032, (USD Million)
Global Large-Volume Wearable Patch Drug Delivery Devices production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Large-Volume Wearable Patch Drug Delivery Devices consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Large-Volume Wearable Patch Drug Delivery Devices domestic production, consumption, key domestic manufacturers and share
Global Large-Volume Wearable Patch Drug Delivery Devices production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Large-Volume Wearable Patch Drug Delivery Devices production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Large-Volume Wearable Patch Drug Delivery Devices production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Large-Volume Wearable Patch Drug Delivery Devices market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ypsomed AG, Enable Injections, Inc., West Pharmaceutical Services, Inc., Becton, Dickinson and Company, LTS Lohmann Therapie-Systeme AG, Gerresheimer AG, Nemera, Stevanato Group S.p.A., Elcam Drug Delivery Devices, CC Biotechnology Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Large-Volume Wearable Patch Drug Delivery Devices market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Large-Volume Wearable Patch Drug Delivery Devices Market, By Region:
1. How big is the global Large-Volume Wearable Patch Drug Delivery Devices market?
2. What is the demand of the global Large-Volume Wearable Patch Drug Delivery Devices market?
3. What is the year over year growth of the global Large-Volume Wearable Patch Drug Delivery Devices market?
4. What is the production and production value of the global Large-Volume Wearable Patch Drug Delivery Devices market?
5. Who are the key producers in the global Large-Volume Wearable Patch Drug Delivery Devices market?
6. What are the growth factors driving the market demand?
In 2025, global sales volume of large-volume wearable patch drug delivery devices was approximately 8.05 million units, with an average price of about US$400 per unit, corresponding to a market size of around US$3.22 billion. A large-volume wearable patch drug delivery device is a sterile, disposable, automated drug delivery system that is preloaded with liquid medication and directly attached to the patient?s skin. It automatically delivers a large dose of drug, typically more than 2 mL and potentially up to 10 mL to 50 mL, into the patient?s body in a controlled, slow, and safe manner through subcutaneous infusion within a defined period, usually ranging from several tens of minutes to several hours. Large-volume wearable drug delivery devices, also known as on-body delivery systems, integrate three core technology modules: miniature power transmission, flexible subcutaneous insertion, and long-duration sterile drug storage. By combining these capabilities, they enable a major shift in drug administration. The technology transforms long-duration, high-dose treatment processes that previously relied on hospital-based intravenous infusion into intelligent, autonomous subcutaneous infusion in the home setting. It has become a key enabling platform for improving patient adherence and reducing healthcare costs in biologics, long-acting GLP-1 drugs, and complex monoclonal antibody therapies.
The growth of large-volume wearable patch drug delivery devices is primarily driven by the structural shift in biologic drug administration. As monoclonal antibodies, fusion proteins, long-acting GLP-1 therapies, and other high-value complex formulations continue to expand, conventional intravenous infusion and short-duration injection formats increasingly face limitations in patient adherence, healthcare resource utilization, and treatment convenience. Large-volume wearable patch delivery devices enable relatively high-volume subcutaneous administration to be performed automatically in home-based settings, creating strong substitution value in chronic disease management, long-term biologic therapy, and frequent treatment scenarios.
On the demand side, the global healthcare system is moving from hospital-centered care toward home-based, outpatient, and patient-managed treatment models. This is the most important long-term driver for the market. For pharmaceutical companies, wearable patch delivery devices are not merely packaging or injection tools; they are strategic platforms for improving drug differentiation, enhancing patient experience, extending product life cycles, and supporting drug-device combination product launches. In particular, the growth of high-viscosity, large-volume, and long-acting formulations is expanding the technical gap that conventional prefilled syringes and autoinjectors cannot fully address, encouraging deeper partnerships between pharmaceutical companies and platform providers such as Enable Injections, West, Ypsomed, BD, Gerresheimer, Stevanato, and Nemera.
On the supply side, the maturation of miniature drive systems, flexible cannula technologies, low-residual fluid paths, sterile drug reservoirs, adhesive systems, and user feedback modules is helping large-volume wearable delivery devices move from concept validation toward commercial-scale adoption. This market is not driven by hardware shipment growth alone. It is closely linked to pharmaceutical pipelines, combination product approvals, supply chain qualification, and patient affordability. As a result, the competitive advantages of leading companies are built around drug-device development experience, quality systems, scalable manufacturing, pharmaceutical customer relationships, and regulatory support capabilities, rather than device cost alone.
Over the next few years, market growth is expected to be supported by three major drivers. First, the continued expansion of biologics and long-acting therapies will create demand for devices capable of handling higher volumes, higher viscosities, and longer delivery durations. Second, healthcare cost containment and hospital capacity pressure will accelerate the shift of selected infusion therapies to home and outpatient settings. Third, patients are increasingly receptive to convenient, less painful, and lower-intervention delivery formats. At the same time, device cost, reliability validation, drug compatibility, regulatory timelines, and pharmaceutical project adoption cycles remain key constraints. Overall, large-volume wearable patch drug delivery devices represent a high-growth but not rapidly commoditized market, where near-term competition will remain led by a limited group of specialized platform companies with mature technologies and strong pharmaceutical partnerships.
This report studies the global Large-Volume Wearable Patch Drug Delivery Devices production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Large-Volume Wearable Patch Drug Delivery Devices and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Large-Volume Wearable Patch Drug Delivery Devices that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Large-Volume Wearable Patch Drug Delivery Devices total production and demand, 2021-2032, (K Units)
Global Large-Volume Wearable Patch Drug Delivery Devices total production value, 2021-2032, (USD Million)
Global Large-Volume Wearable Patch Drug Delivery Devices production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (K Units), (based on production site)
Global Large-Volume Wearable Patch Drug Delivery Devices consumption by region & country, CAGR, 2021-2032 & (K Units)
U.S. VS China: Large-Volume Wearable Patch Drug Delivery Devices domestic production, consumption, key domestic manufacturers and share
Global Large-Volume Wearable Patch Drug Delivery Devices production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (K Units)
Global Large-Volume Wearable Patch Drug Delivery Devices production by Type, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
Global Large-Volume Wearable Patch Drug Delivery Devices production by Application, production, value, CAGR, 2021-2032, (USD Million) & (K Units)
This report profiles key players in the global Large-Volume Wearable Patch Drug Delivery Devices market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ypsomed AG, Enable Injections, Inc., West Pharmaceutical Services, Inc., Becton, Dickinson and Company, LTS Lohmann Therapie-Systeme AG, Gerresheimer AG, Nemera, Stevanato Group S.p.A., Elcam Drug Delivery Devices, CC Biotechnology Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Large-Volume Wearable Patch Drug Delivery Devices market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Large-Volume Wearable Patch Drug Delivery Devices Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Fully Disposable Patch Delivery Device
- Reusable Controller Patch Delivery Device
- Other
- Low Volume Patch Delivery Device
- Medium Volume Patch Delivery Device
- High Volume Patch Delivery Device
- Other
- Mechanical Drive Patch Delivery Device
- Electromechanical Drive Patch Delivery Device
- Micropump Drive Patch Delivery Device
- Magnetic Coupling Drive Patch Delivery Device
- Other
- Large Molecule Biologic Delivery
- Small Molecule Injectable Delivery
- Other
- Ypsomed AG
- Enable Injections, Inc.
- West Pharmaceutical Services, Inc.
- Becton, Dickinson and Company
- LTS Lohmann Therapie-Systeme AG
- Gerresheimer AG
- Nemera
- Stevanato Group S.p.A.
- Elcam Drug Delivery Devices
- CC Biotechnology Corporation
1. How big is the global Large-Volume Wearable Patch Drug Delivery Devices market?
2. What is the demand of the global Large-Volume Wearable Patch Drug Delivery Devices market?
3. What is the year over year growth of the global Large-Volume Wearable Patch Drug Delivery Devices market?
4. What is the production and production value of the global Large-Volume Wearable Patch Drug Delivery Devices market?
5. Who are the key producers in the global Large-Volume Wearable Patch Drug Delivery Devices market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Large-Volume Wearable Patch Drug Delivery Devices Introduction
1.2 World Large-Volume Wearable Patch Drug Delivery Devices Supply & Forecast
1.2.1 World Large-Volume Wearable Patch Drug Delivery Devices Production Value (2021 & 2025 & 2032)
1.2.2 World Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2032)
1.2.3 World Large-Volume Wearable Patch Drug Delivery Devices Pricing Trends (2021-2032)
1.3 World Large-Volume Wearable Patch Drug Delivery Devices Production by Region (Based on Production Site)
1.3.1 World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Region (2021-2032)
1.3.2 World Large-Volume Wearable Patch Drug Delivery Devices Production by Region (2021-2032)
1.3.3 World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Region (2021-2032)
1.3.4 North America Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2032)
1.3.5 Europe Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2032)
1.3.6 China Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2032)
1.3.7 Japan Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Large-Volume Wearable Patch Drug Delivery Devices Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Large-Volume Wearable Patch Drug Delivery Devices Major Market Trends
2 DEMAND SUMMARY
2.1 World Large-Volume Wearable Patch Drug Delivery Devices Demand (2021-2032)
2.2 World Large-Volume Wearable Patch Drug Delivery Devices Consumption by Region
2.2.1 World Large-Volume Wearable Patch Drug Delivery Devices Consumption by Region (2021-2026)
2.2.2 World Large-Volume Wearable Patch Drug Delivery Devices Consumption Forecast by Region (2027-2032)
2.3 United States Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032)
2.4 China Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032)
2.5 Europe Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032)
2.6 Japan Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032)
2.7 South Korea Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032)
2.8 ASEAN Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032)
2.9 India Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Manufacturer (2021-2026)
3.2 World Large-Volume Wearable Patch Drug Delivery Devices Production by Manufacturer (2021-2026)
3.3 World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Manufacturer (2021-2026)
3.4 Large-Volume Wearable Patch Drug Delivery Devices Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Large-Volume Wearable Patch Drug Delivery Devices Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Large-Volume Wearable Patch Drug Delivery Devices in 2025
3.5.3 Global Concentration Ratios (CR8) for Large-Volume Wearable Patch Drug Delivery Devices in 2025
3.6 Large-Volume Wearable Patch Drug Delivery Devices Market: Overall Company Footprint Analysis
3.6.1 Large-Volume Wearable Patch Drug Delivery Devices Market: Region Footprint
3.6.2 Large-Volume Wearable Patch Drug Delivery Devices Market: Company Product Type Footprint
3.6.3 Large-Volume Wearable Patch Drug Delivery Devices Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Production Value Comparison
4.1.1 United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Production Comparison
4.2.1 United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Consumption Comparison
4.3.1 United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Large-Volume Wearable Patch Drug Delivery Devices Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Large-Volume Wearable Patch Drug Delivery Devices Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Value (2021-2026)
4.4.3 United States Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2026)
4.5 China Based Large-Volume Wearable Patch Drug Delivery Devices Manufacturers and Market Share
4.5.1 China Based Large-Volume Wearable Patch Drug Delivery Devices Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Value (2021-2026)
4.5.3 China Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2026)
4.6 Rest of World Based Large-Volume Wearable Patch Drug Delivery Devices Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Large-Volume Wearable Patch Drug Delivery Devices Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Large-Volume Wearable Patch Drug Delivery Devices Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Fully Disposable Patch Delivery Device
5.2.2 Reusable Controller Patch Delivery Device
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Large-Volume Wearable Patch Drug Delivery Devices Production by Type (2021-2032)
5.3.2 World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Type (2021-2032)
5.3.3 World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DRIVE MECHANISM
6.1 World Large-Volume Wearable Patch Drug Delivery Devices Market Size Overview by Drive Mechanism: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Drive Mechanism
6.2.1 Low Volume Patch Delivery Device
6.2.2 Medium Volume Patch Delivery Device
6.2.3 High Volume Patch Delivery Device
6.2.4 Other
6.3 Market Segment by Drive Mechanism
6.3.1 World Large-Volume Wearable Patch Drug Delivery Devices Production by Drive Mechanism (2021-2032)
6.3.2 World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Drive Mechanism (2021-2032)
6.3.3 World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Drive Mechanism (2021-2032)
7 MARKET ANALYSIS BY DRUG LOADING CONFIGURATION
7.1 World Large-Volume Wearable Patch Drug Delivery Devices Market Size Overview by Drug Loading Configuration: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Drug Loading Configuration
7.2.1 Mechanical Drive Patch Delivery Device
7.2.2 Electromechanical Drive Patch Delivery Device
7.2.3 Micropump Drive Patch Delivery Device
7.2.4 Magnetic Coupling Drive Patch Delivery Device
7.2.5 Other
7.3 Market Segment by Drug Loading Configuration
7.3.1 World Large-Volume Wearable Patch Drug Delivery Devices Production by Drug Loading Configuration (2021-2032)
7.3.2 World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Drug Loading Configuration (2021-2032)
7.3.3 World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Drug Loading Configuration (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Large-Volume Wearable Patch Drug Delivery Devices Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Large Molecule Biologic Delivery
8.2.2 Small Molecule Injectable Delivery
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Large-Volume Wearable Patch Drug Delivery Devices Production by Application (2021-2032)
8.3.2 World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Application (2021-2032)
8.3.3 World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Ypsomed AG
9.1.1 Ypsomed AG Details
9.1.2 Ypsomed AG Major Business
9.1.3 Ypsomed AG Large-Volume Wearable Patch Drug Delivery Devices Product and Services
9.1.4 Ypsomed AG Large-Volume Wearable Patch Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Ypsomed AG Recent Developments/Updates
9.1.6 Ypsomed AG Competitive Strengths & Weaknesses
9.2 Enable Injections, Inc.
9.2.1 Enable Injections, Inc. Details
9.2.2 Enable Injections, Inc. Major Business
9.2.3 Enable Injections, Inc. Large-Volume Wearable Patch Drug Delivery Devices Product and Services
9.2.4 Enable Injections, Inc. Large-Volume Wearable Patch Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Enable Injections, Inc. Recent Developments/Updates
9.2.6 Enable Injections, Inc. Competitive Strengths & Weaknesses
9.3 West Pharmaceutical Services, Inc.
9.3.1 West Pharmaceutical Services, Inc. Details
9.3.2 West Pharmaceutical Services, Inc. Major Business
9.3.3 West Pharmaceutical Services, Inc. Large-Volume Wearable Patch Drug Delivery Devices Product and Services
9.3.4 West Pharmaceutical Services, Inc. Large-Volume Wearable Patch Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 West Pharmaceutical Services, Inc. Recent Developments/Updates
9.3.6 West Pharmaceutical Services, Inc. Competitive Strengths & Weaknesses
9.4 Becton, Dickinson and Company
9.4.1 Becton, Dickinson and Company Details
9.4.2 Becton, Dickinson and Company Major Business
9.4.3 Becton, Dickinson and Company Large-Volume Wearable Patch Drug Delivery Devices Product and Services
9.4.4 Becton, Dickinson and Company Large-Volume Wearable Patch Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Becton, Dickinson and Company Recent Developments/Updates
9.4.6 Becton, Dickinson and Company Competitive Strengths & Weaknesses
9.5 LTS Lohmann Therapie-Systeme AG
9.5.1 LTS Lohmann Therapie-Systeme AG Details
9.5.2 LTS Lohmann Therapie-Systeme AG Major Business
9.5.3 LTS Lohmann Therapie-Systeme AG Large-Volume Wearable Patch Drug Delivery Devices Product and Services
9.5.4 LTS Lohmann Therapie-Systeme AG Large-Volume Wearable Patch Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 LTS Lohmann Therapie-Systeme AG Recent Developments/Updates
9.5.6 LTS Lohmann Therapie-Systeme AG Competitive Strengths & Weaknesses
9.6 Gerresheimer AG
9.6.1 Gerresheimer AG Details
9.6.2 Gerresheimer AG Major Business
9.6.3 Gerresheimer AG Large-Volume Wearable Patch Drug Delivery Devices Product and Services
9.6.4 Gerresheimer AG Large-Volume Wearable Patch Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Gerresheimer AG Recent Developments/Updates
9.6.6 Gerresheimer AG Competitive Strengths & Weaknesses
9.7 Nemera
9.7.1 Nemera Details
9.7.2 Nemera Major Business
9.7.3 Nemera Large-Volume Wearable Patch Drug Delivery Devices Product and Services
9.7.4 Nemera Large-Volume Wearable Patch Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Nemera Recent Developments/Updates
9.7.6 Nemera Competitive Strengths & Weaknesses
9.8 Stevanato Group S.p.A.
9.8.1 Stevanato Group S.p.A. Details
9.8.2 Stevanato Group S.p.A. Major Business
9.8.3 Stevanato Group S.p.A. Large-Volume Wearable Patch Drug Delivery Devices Product and Services
9.8.4 Stevanato Group S.p.A. Large-Volume Wearable Patch Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Stevanato Group S.p.A. Recent Developments/Updates
9.8.6 Stevanato Group S.p.A. Competitive Strengths & Weaknesses
9.9 Elcam Drug Delivery Devices
9.9.1 Elcam Drug Delivery Devices Details
9.9.2 Elcam Drug Delivery Devices Major Business
9.9.3 Elcam Drug Delivery Devices Large-Volume Wearable Patch Drug Delivery Devices Product and Services
9.9.4 Elcam Drug Delivery Devices Large-Volume Wearable Patch Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Elcam Drug Delivery Devices Recent Developments/Updates
9.9.6 Elcam Drug Delivery Devices Competitive Strengths & Weaknesses
9.10 CC Biotechnology Corporation
9.10.1 CC Biotechnology Corporation Details
9.10.2 CC Biotechnology Corporation Major Business
9.10.3 CC Biotechnology Corporation Large-Volume Wearable Patch Drug Delivery Devices Product and Services
9.10.4 CC Biotechnology Corporation Large-Volume Wearable Patch Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 CC Biotechnology Corporation Recent Developments/Updates
9.10.6 CC Biotechnology Corporation Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Large-Volume Wearable Patch Drug Delivery Devices Industry Chain
10.2 Large-Volume Wearable Patch Drug Delivery Devices Upstream Analysis
10.2.1 Large-Volume Wearable Patch Drug Delivery Devices Core Raw Materials
10.2.2 Main Manufacturers of Large-Volume Wearable Patch Drug Delivery Devices Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Large-Volume Wearable Patch Drug Delivery Devices Production Mode
10.6 Large-Volume Wearable Patch Drug Delivery Devices Procurement Model
10.7 Large-Volume Wearable Patch Drug Delivery Devices Industry Sales Model and Sales Channels
10.7.1 Large-Volume Wearable Patch Drug Delivery Devices Sales Model
10.7.2 Large-Volume Wearable Patch Drug Delivery Devices Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Large-Volume Wearable Patch Drug Delivery Devices Introduction
1.2 World Large-Volume Wearable Patch Drug Delivery Devices Supply & Forecast
1.2.1 World Large-Volume Wearable Patch Drug Delivery Devices Production Value (2021 & 2025 & 2032)
1.2.2 World Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2032)
1.2.3 World Large-Volume Wearable Patch Drug Delivery Devices Pricing Trends (2021-2032)
1.3 World Large-Volume Wearable Patch Drug Delivery Devices Production by Region (Based on Production Site)
1.3.1 World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Region (2021-2032)
1.3.2 World Large-Volume Wearable Patch Drug Delivery Devices Production by Region (2021-2032)
1.3.3 World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Region (2021-2032)
1.3.4 North America Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2032)
1.3.5 Europe Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2032)
1.3.6 China Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2032)
1.3.7 Japan Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Large-Volume Wearable Patch Drug Delivery Devices Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Large-Volume Wearable Patch Drug Delivery Devices Major Market Trends
2 DEMAND SUMMARY
2.1 World Large-Volume Wearable Patch Drug Delivery Devices Demand (2021-2032)
2.2 World Large-Volume Wearable Patch Drug Delivery Devices Consumption by Region
2.2.1 World Large-Volume Wearable Patch Drug Delivery Devices Consumption by Region (2021-2026)
2.2.2 World Large-Volume Wearable Patch Drug Delivery Devices Consumption Forecast by Region (2027-2032)
2.3 United States Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032)
2.4 China Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032)
2.5 Europe Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032)
2.6 Japan Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032)
2.7 South Korea Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032)
2.8 ASEAN Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032)
2.9 India Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Manufacturer (2021-2026)
3.2 World Large-Volume Wearable Patch Drug Delivery Devices Production by Manufacturer (2021-2026)
3.3 World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Manufacturer (2021-2026)
3.4 Large-Volume Wearable Patch Drug Delivery Devices Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Large-Volume Wearable Patch Drug Delivery Devices Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Large-Volume Wearable Patch Drug Delivery Devices in 2025
3.5.3 Global Concentration Ratios (CR8) for Large-Volume Wearable Patch Drug Delivery Devices in 2025
3.6 Large-Volume Wearable Patch Drug Delivery Devices Market: Overall Company Footprint Analysis
3.6.1 Large-Volume Wearable Patch Drug Delivery Devices Market: Region Footprint
3.6.2 Large-Volume Wearable Patch Drug Delivery Devices Market: Company Product Type Footprint
3.6.3 Large-Volume Wearable Patch Drug Delivery Devices Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Production Value Comparison
4.1.1 United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Production Comparison
4.2.1 United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Consumption Comparison
4.3.1 United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Large-Volume Wearable Patch Drug Delivery Devices Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Large-Volume Wearable Patch Drug Delivery Devices Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Value (2021-2026)
4.4.3 United States Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2026)
4.5 China Based Large-Volume Wearable Patch Drug Delivery Devices Manufacturers and Market Share
4.5.1 China Based Large-Volume Wearable Patch Drug Delivery Devices Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Value (2021-2026)
4.5.3 China Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2026)
4.6 Rest of World Based Large-Volume Wearable Patch Drug Delivery Devices Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Large-Volume Wearable Patch Drug Delivery Devices Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Large-Volume Wearable Patch Drug Delivery Devices Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Fully Disposable Patch Delivery Device
5.2.2 Reusable Controller Patch Delivery Device
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Large-Volume Wearable Patch Drug Delivery Devices Production by Type (2021-2032)
5.3.2 World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Type (2021-2032)
5.3.3 World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DRIVE MECHANISM
6.1 World Large-Volume Wearable Patch Drug Delivery Devices Market Size Overview by Drive Mechanism: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Drive Mechanism
6.2.1 Low Volume Patch Delivery Device
6.2.2 Medium Volume Patch Delivery Device
6.2.3 High Volume Patch Delivery Device
6.2.4 Other
6.3 Market Segment by Drive Mechanism
6.3.1 World Large-Volume Wearable Patch Drug Delivery Devices Production by Drive Mechanism (2021-2032)
6.3.2 World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Drive Mechanism (2021-2032)
6.3.3 World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Drive Mechanism (2021-2032)
7 MARKET ANALYSIS BY DRUG LOADING CONFIGURATION
7.1 World Large-Volume Wearable Patch Drug Delivery Devices Market Size Overview by Drug Loading Configuration: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Drug Loading Configuration
7.2.1 Mechanical Drive Patch Delivery Device
7.2.2 Electromechanical Drive Patch Delivery Device
7.2.3 Micropump Drive Patch Delivery Device
7.2.4 Magnetic Coupling Drive Patch Delivery Device
7.2.5 Other
7.3 Market Segment by Drug Loading Configuration
7.3.1 World Large-Volume Wearable Patch Drug Delivery Devices Production by Drug Loading Configuration (2021-2032)
7.3.2 World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Drug Loading Configuration (2021-2032)
7.3.3 World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Drug Loading Configuration (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Large-Volume Wearable Patch Drug Delivery Devices Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Large Molecule Biologic Delivery
8.2.2 Small Molecule Injectable Delivery
8.2.3 Other
8.3 Market Segment by Application
8.3.1 World Large-Volume Wearable Patch Drug Delivery Devices Production by Application (2021-2032)
8.3.2 World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Application (2021-2032)
8.3.3 World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Ypsomed AG
9.1.1 Ypsomed AG Details
9.1.2 Ypsomed AG Major Business
9.1.3 Ypsomed AG Large-Volume Wearable Patch Drug Delivery Devices Product and Services
9.1.4 Ypsomed AG Large-Volume Wearable Patch Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Ypsomed AG Recent Developments/Updates
9.1.6 Ypsomed AG Competitive Strengths & Weaknesses
9.2 Enable Injections, Inc.
9.2.1 Enable Injections, Inc. Details
9.2.2 Enable Injections, Inc. Major Business
9.2.3 Enable Injections, Inc. Large-Volume Wearable Patch Drug Delivery Devices Product and Services
9.2.4 Enable Injections, Inc. Large-Volume Wearable Patch Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Enable Injections, Inc. Recent Developments/Updates
9.2.6 Enable Injections, Inc. Competitive Strengths & Weaknesses
9.3 West Pharmaceutical Services, Inc.
9.3.1 West Pharmaceutical Services, Inc. Details
9.3.2 West Pharmaceutical Services, Inc. Major Business
9.3.3 West Pharmaceutical Services, Inc. Large-Volume Wearable Patch Drug Delivery Devices Product and Services
9.3.4 West Pharmaceutical Services, Inc. Large-Volume Wearable Patch Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 West Pharmaceutical Services, Inc. Recent Developments/Updates
9.3.6 West Pharmaceutical Services, Inc. Competitive Strengths & Weaknesses
9.4 Becton, Dickinson and Company
9.4.1 Becton, Dickinson and Company Details
9.4.2 Becton, Dickinson and Company Major Business
9.4.3 Becton, Dickinson and Company Large-Volume Wearable Patch Drug Delivery Devices Product and Services
9.4.4 Becton, Dickinson and Company Large-Volume Wearable Patch Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 Becton, Dickinson and Company Recent Developments/Updates
9.4.6 Becton, Dickinson and Company Competitive Strengths & Weaknesses
9.5 LTS Lohmann Therapie-Systeme AG
9.5.1 LTS Lohmann Therapie-Systeme AG Details
9.5.2 LTS Lohmann Therapie-Systeme AG Major Business
9.5.3 LTS Lohmann Therapie-Systeme AG Large-Volume Wearable Patch Drug Delivery Devices Product and Services
9.5.4 LTS Lohmann Therapie-Systeme AG Large-Volume Wearable Patch Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 LTS Lohmann Therapie-Systeme AG Recent Developments/Updates
9.5.6 LTS Lohmann Therapie-Systeme AG Competitive Strengths & Weaknesses
9.6 Gerresheimer AG
9.6.1 Gerresheimer AG Details
9.6.2 Gerresheimer AG Major Business
9.6.3 Gerresheimer AG Large-Volume Wearable Patch Drug Delivery Devices Product and Services
9.6.4 Gerresheimer AG Large-Volume Wearable Patch Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Gerresheimer AG Recent Developments/Updates
9.6.6 Gerresheimer AG Competitive Strengths & Weaknesses
9.7 Nemera
9.7.1 Nemera Details
9.7.2 Nemera Major Business
9.7.3 Nemera Large-Volume Wearable Patch Drug Delivery Devices Product and Services
9.7.4 Nemera Large-Volume Wearable Patch Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Nemera Recent Developments/Updates
9.7.6 Nemera Competitive Strengths & Weaknesses
9.8 Stevanato Group S.p.A.
9.8.1 Stevanato Group S.p.A. Details
9.8.2 Stevanato Group S.p.A. Major Business
9.8.3 Stevanato Group S.p.A. Large-Volume Wearable Patch Drug Delivery Devices Product and Services
9.8.4 Stevanato Group S.p.A. Large-Volume Wearable Patch Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Stevanato Group S.p.A. Recent Developments/Updates
9.8.6 Stevanato Group S.p.A. Competitive Strengths & Weaknesses
9.9 Elcam Drug Delivery Devices
9.9.1 Elcam Drug Delivery Devices Details
9.9.2 Elcam Drug Delivery Devices Major Business
9.9.3 Elcam Drug Delivery Devices Large-Volume Wearable Patch Drug Delivery Devices Product and Services
9.9.4 Elcam Drug Delivery Devices Large-Volume Wearable Patch Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.9.5 Elcam Drug Delivery Devices Recent Developments/Updates
9.9.6 Elcam Drug Delivery Devices Competitive Strengths & Weaknesses
9.10 CC Biotechnology Corporation
9.10.1 CC Biotechnology Corporation Details
9.10.2 CC Biotechnology Corporation Major Business
9.10.3 CC Biotechnology Corporation Large-Volume Wearable Patch Drug Delivery Devices Product and Services
9.10.4 CC Biotechnology Corporation Large-Volume Wearable Patch Drug Delivery Devices Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.10.5 CC Biotechnology Corporation Recent Developments/Updates
9.10.6 CC Biotechnology Corporation Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Large-Volume Wearable Patch Drug Delivery Devices Industry Chain
10.2 Large-Volume Wearable Patch Drug Delivery Devices Upstream Analysis
10.2.1 Large-Volume Wearable Patch Drug Delivery Devices Core Raw Materials
10.2.2 Main Manufacturers of Large-Volume Wearable Patch Drug Delivery Devices Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Large-Volume Wearable Patch Drug Delivery Devices Production Mode
10.6 Large-Volume Wearable Patch Drug Delivery Devices Procurement Model
10.7 Large-Volume Wearable Patch Drug Delivery Devices Industry Sales Model and Sales Channels
10.7.1 Large-Volume Wearable Patch Drug Delivery Devices Sales Model
10.7.2 Large-Volume Wearable Patch Drug Delivery Devices Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Region (2021-2026) & (USD Million)
Table 3. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Region (2027-2032) & (USD Million)
Table 4. World Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share by Region (2021-2026)
Table 5. World Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share by Region (2027-2032)
Table 6. World Large-Volume Wearable Patch Drug Delivery Devices Production by Region (2021-2026) & (K Units)
Table 7. World Large-Volume Wearable Patch Drug Delivery Devices Production by Region (2027-2032) & (K Units)
Table 8. World Large-Volume Wearable Patch Drug Delivery Devices Production Market Share by Region (2021-2026)
Table 9. World Large-Volume Wearable Patch Drug Delivery Devices Production Market Share by Region (2027-2032)
Table 10. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Large-Volume Wearable Patch Drug Delivery Devices Major Market Trends
Table 13. World Large-Volume Wearable Patch Drug Delivery Devices Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Large-Volume Wearable Patch Drug Delivery Devices Consumption by Region (2021-2026) & (K Units)
Table 15. World Large-Volume Wearable Patch Drug Delivery Devices Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Large-Volume Wearable Patch Drug Delivery Devices Producers in 2025
Table 18. World Large-Volume Wearable Patch Drug Delivery Devices Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Large-Volume Wearable Patch Drug Delivery Devices Producers in 2025
Table 20. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Large-Volume Wearable Patch Drug Delivery Devices Company Evaluation Quadrant
Table 22. World Large-Volume Wearable Patch Drug Delivery Devices Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Large-Volume Wearable Patch Drug Delivery Devices Production Site of Key Manufacturer
Table 24. Large-Volume Wearable Patch Drug Delivery Devices Market: Company Product Type Footprint
Table 25. Large-Volume Wearable Patch Drug Delivery Devices Market: Company Product Application Footprint
Table 26. Large-Volume Wearable Patch Drug Delivery Devices Competitive Factors
Table 27. Large-Volume Wearable Patch Drug Delivery Devices New Entrant and Capacity Expansion Plans
Table 28. Large-Volume Wearable Patch Drug Delivery Devices Mergers & Acquisitions Activity
Table 29. United States VS China Large-Volume Wearable Patch Drug Delivery Devices Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Large-Volume Wearable Patch Drug Delivery Devices Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Large-Volume Wearable Patch Drug Delivery Devices Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Large-Volume Wearable Patch Drug Delivery Devices Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Market Share (2021-2026)
Table 37. China Based Large-Volume Wearable Patch Drug Delivery Devices Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Market Share (2021-2026)
Table 42. Rest of World Based Large-Volume Wearable Patch Drug Delivery Devices Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Market Share (2021-2026)
Table 47. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Large-Volume Wearable Patch Drug Delivery Devices Production by Type (2021-2026) & (K Units)
Table 49. World Large-Volume Wearable Patch Drug Delivery Devices Production by Type (2027-2032) & (K Units)
Table 50. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Type (2021-2026) & (USD Million)
Table 51. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Type (2027-2032) & (USD Million)
Table 52. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Drive Mechanism, (USD Million), 2021 & 2025 & 2032
Table 55. World Large-Volume Wearable Patch Drug Delivery Devices Production by Drive Mechanism (2021-2026) & (K Units)
Table 56. World Large-Volume Wearable Patch Drug Delivery Devices Production by Drive Mechanism (2027-2032) & (K Units)
Table 57. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Drive Mechanism (2021-2026) & (USD Million)
Table 58. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Drive Mechanism (2027-2032) & (USD Million)
Table 59. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Drive Mechanism (2021-2026) & (US$/Unit)
Table 60. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Drive Mechanism (2027-2032) & (US$/Unit)
Table 61. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Drug Loading Configuration, (USD Million), 2021 & 2025 & 2032
Table 62. World Large-Volume Wearable Patch Drug Delivery Devices Production by Drug Loading Configuration (2021-2026) & (K Units)
Table 63. World Large-Volume Wearable Patch Drug Delivery Devices Production by Drug Loading Configuration (2027-2032) & (K Units)
Table 64. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Drug Loading Configuration (2021-2026) & (USD Million)
Table 65. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Drug Loading Configuration (2027-2032) & (USD Million)
Table 66. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Drug Loading Configuration (2021-2026) & (US$/Unit)
Table 67. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Drug Loading Configuration (2027-2032) & (US$/Unit)
Table 68. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Large-Volume Wearable Patch Drug Delivery Devices Production by Application (2021-2026) & (K Units)
Table 70. World Large-Volume Wearable Patch Drug Delivery Devices Production by Application (2027-2032) & (K Units)
Table 71. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Application (2021-2026) & (USD Million)
Table 72. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Application (2027-2032) & (USD Million)
Table 73. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Ypsomed AG Basic Information, Manufacturing Base and Competitors
Table 76. Ypsomed AG Major Business
Table 77. Ypsomed AG Large-Volume Wearable Patch Drug Delivery Devices Product and Services
Table 78. Ypsomed AG Large-Volume Wearable Patch Drug Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Ypsomed AG Recent Developments/Updates
Table 80. Ypsomed AG Competitive Strengths & Weaknesses
Table 81. Enable Injections, Inc. Basic Information, Manufacturing Base and Competitors
Table 82. Enable Injections, Inc. Major Business
Table 83. Enable Injections, Inc. Large-Volume Wearable Patch Drug Delivery Devices Product and Services
Table 84. Enable Injections, Inc. Large-Volume Wearable Patch Drug Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Enable Injections, Inc. Recent Developments/Updates
Table 86. Enable Injections, Inc. Competitive Strengths & Weaknesses
Table 87. West Pharmaceutical Services, Inc. Basic Information, Manufacturing Base and Competitors
Table 88. West Pharmaceutical Services, Inc. Major Business
Table 89. West Pharmaceutical Services, Inc. Large-Volume Wearable Patch Drug Delivery Devices Product and Services
Table 90. West Pharmaceutical Services, Inc. Large-Volume Wearable Patch Drug Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. West Pharmaceutical Services, Inc. Recent Developments/Updates
Table 92. West Pharmaceutical Services, Inc. Competitive Strengths & Weaknesses
Table 93. Becton, Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table 94. Becton, Dickinson and Company Major Business
Table 95. Becton, Dickinson and Company Large-Volume Wearable Patch Drug Delivery Devices Product and Services
Table 96. Becton, Dickinson and Company Large-Volume Wearable Patch Drug Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Becton, Dickinson and Company Recent Developments/Updates
Table 98. Becton, Dickinson and Company Competitive Strengths & Weaknesses
Table 99. LTS Lohmann Therapie-Systeme AG Basic Information, Manufacturing Base and Competitors
Table 100. LTS Lohmann Therapie-Systeme AG Major Business
Table 101. LTS Lohmann Therapie-Systeme AG Large-Volume Wearable Patch Drug Delivery Devices Product and Services
Table 102. LTS Lohmann Therapie-Systeme AG Large-Volume Wearable Patch Drug Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. LTS Lohmann Therapie-Systeme AG Recent Developments/Updates
Table 104. LTS Lohmann Therapie-Systeme AG Competitive Strengths & Weaknesses
Table 105. Gerresheimer AG Basic Information, Manufacturing Base and Competitors
Table 106. Gerresheimer AG Major Business
Table 107. Gerresheimer AG Large-Volume Wearable Patch Drug Delivery Devices Product and Services
Table 108. Gerresheimer AG Large-Volume Wearable Patch Drug Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Gerresheimer AG Recent Developments/Updates
Table 110. Gerresheimer AG Competitive Strengths & Weaknesses
Table 111. Nemera Basic Information, Manufacturing Base and Competitors
Table 112. Nemera Major Business
Table 113. Nemera Large-Volume Wearable Patch Drug Delivery Devices Product and Services
Table 114. Nemera Large-Volume Wearable Patch Drug Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Nemera Recent Developments/Updates
Table 116. Nemera Competitive Strengths & Weaknesses
Table 117. Stevanato Group S.p.A. Basic Information, Manufacturing Base and Competitors
Table 118. Stevanato Group S.p.A. Major Business
Table 119. Stevanato Group S.p.A. Large-Volume Wearable Patch Drug Delivery Devices Product and Services
Table 120. Stevanato Group S.p.A. Large-Volume Wearable Patch Drug Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Stevanato Group S.p.A. Recent Developments/Updates
Table 122. Stevanato Group S.p.A. Competitive Strengths & Weaknesses
Table 123. Elcam Drug Delivery Devices Basic Information, Manufacturing Base and Competitors
Table 124. Elcam Drug Delivery Devices Major Business
Table 125. Elcam Drug Delivery Devices Large-Volume Wearable Patch Drug Delivery Devices Product and Services
Table 126. Elcam Drug Delivery Devices Large-Volume Wearable Patch Drug Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Elcam Drug Delivery Devices Recent Developments/Updates
Table 128. Elcam Drug Delivery Devices Competitive Strengths & Weaknesses
Table 129. CC Biotechnology Corporation Basic Information, Manufacturing Base and Competitors
Table 130. CC Biotechnology Corporation Major Business
Table 131. CC Biotechnology Corporation Large-Volume Wearable Patch Drug Delivery Devices Product and Services
Table 132. CC Biotechnology Corporation Large-Volume Wearable Patch Drug Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. CC Biotechnology Corporation Recent Developments/Updates
Table 134. CC Biotechnology Corporation Competitive Strengths & Weaknesses
Table 135. Global Key Players of Large-Volume Wearable Patch Drug Delivery Devices Upstream (Raw Materials)
Table 136. Global Large-Volume Wearable Patch Drug Delivery Devices Typical Customers
Table 137. Large-Volume Wearable Patch Drug Delivery Devices Typical Distributors
Table 1. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Region (2021-2026) & (USD Million)
Table 3. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Region (2027-2032) & (USD Million)
Table 4. World Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share by Region (2021-2026)
Table 5. World Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share by Region (2027-2032)
Table 6. World Large-Volume Wearable Patch Drug Delivery Devices Production by Region (2021-2026) & (K Units)
Table 7. World Large-Volume Wearable Patch Drug Delivery Devices Production by Region (2027-2032) & (K Units)
Table 8. World Large-Volume Wearable Patch Drug Delivery Devices Production Market Share by Region (2021-2026)
Table 9. World Large-Volume Wearable Patch Drug Delivery Devices Production Market Share by Region (2027-2032)
Table 10. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Region (2021-2026) & (US$/Unit)
Table 11. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Region (2027-2032) & (US$/Unit)
Table 12. Large-Volume Wearable Patch Drug Delivery Devices Major Market Trends
Table 13. World Large-Volume Wearable Patch Drug Delivery Devices Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (K Units)
Table 14. World Large-Volume Wearable Patch Drug Delivery Devices Consumption by Region (2021-2026) & (K Units)
Table 15. World Large-Volume Wearable Patch Drug Delivery Devices Consumption Forecast by Region (2027-2032) & (K Units)
Table 16. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Large-Volume Wearable Patch Drug Delivery Devices Producers in 2025
Table 18. World Large-Volume Wearable Patch Drug Delivery Devices Production by Manufacturer (2021-2026) & (K Units)
Table 19. Production Market Share of Key Large-Volume Wearable Patch Drug Delivery Devices Producers in 2025
Table 20. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Manufacturer (2021-2026) & (US$/Unit)
Table 21. Global Large-Volume Wearable Patch Drug Delivery Devices Company Evaluation Quadrant
Table 22. World Large-Volume Wearable Patch Drug Delivery Devices Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Large-Volume Wearable Patch Drug Delivery Devices Production Site of Key Manufacturer
Table 24. Large-Volume Wearable Patch Drug Delivery Devices Market: Company Product Type Footprint
Table 25. Large-Volume Wearable Patch Drug Delivery Devices Market: Company Product Application Footprint
Table 26. Large-Volume Wearable Patch Drug Delivery Devices Competitive Factors
Table 27. Large-Volume Wearable Patch Drug Delivery Devices New Entrant and Capacity Expansion Plans
Table 28. Large-Volume Wearable Patch Drug Delivery Devices Mergers & Acquisitions Activity
Table 29. United States VS China Large-Volume Wearable Patch Drug Delivery Devices Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Large-Volume Wearable Patch Drug Delivery Devices Production Comparison, (2021 & 2025 & 2032) & (K Units)
Table 31. United States VS China Large-Volume Wearable Patch Drug Delivery Devices Consumption Comparison, (2021 & 2025 & 2032) & (K Units)
Table 32. United States Based Large-Volume Wearable Patch Drug Delivery Devices Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2026) & (K Units)
Table 36. United States Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Market Share (2021-2026)
Table 37. China Based Large-Volume Wearable Patch Drug Delivery Devices Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production, (2021-2026) & (K Units)
Table 41. China Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Market Share (2021-2026)
Table 42. Rest of World Based Large-Volume Wearable Patch Drug Delivery Devices Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production, (2021-2026) & (K Units)
Table 46. Rest of World Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Market Share (2021-2026)
Table 47. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Large-Volume Wearable Patch Drug Delivery Devices Production by Type (2021-2026) & (K Units)
Table 49. World Large-Volume Wearable Patch Drug Delivery Devices Production by Type (2027-2032) & (K Units)
Table 50. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Type (2021-2026) & (USD Million)
Table 51. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Type (2027-2032) & (USD Million)
Table 52. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Type (2021-2026) & (US$/Unit)
Table 53. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Type (2027-2032) & (US$/Unit)
Table 54. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Drive Mechanism, (USD Million), 2021 & 2025 & 2032
Table 55. World Large-Volume Wearable Patch Drug Delivery Devices Production by Drive Mechanism (2021-2026) & (K Units)
Table 56. World Large-Volume Wearable Patch Drug Delivery Devices Production by Drive Mechanism (2027-2032) & (K Units)
Table 57. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Drive Mechanism (2021-2026) & (USD Million)
Table 58. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Drive Mechanism (2027-2032) & (USD Million)
Table 59. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Drive Mechanism (2021-2026) & (US$/Unit)
Table 60. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Drive Mechanism (2027-2032) & (US$/Unit)
Table 61. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Drug Loading Configuration, (USD Million), 2021 & 2025 & 2032
Table 62. World Large-Volume Wearable Patch Drug Delivery Devices Production by Drug Loading Configuration (2021-2026) & (K Units)
Table 63. World Large-Volume Wearable Patch Drug Delivery Devices Production by Drug Loading Configuration (2027-2032) & (K Units)
Table 64. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Drug Loading Configuration (2021-2026) & (USD Million)
Table 65. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Drug Loading Configuration (2027-2032) & (USD Million)
Table 66. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Drug Loading Configuration (2021-2026) & (US$/Unit)
Table 67. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Drug Loading Configuration (2027-2032) & (US$/Unit)
Table 68. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Large-Volume Wearable Patch Drug Delivery Devices Production by Application (2021-2026) & (K Units)
Table 70. World Large-Volume Wearable Patch Drug Delivery Devices Production by Application (2027-2032) & (K Units)
Table 71. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Application (2021-2026) & (USD Million)
Table 72. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Application (2027-2032) & (USD Million)
Table 73. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Application (2021-2026) & (US$/Unit)
Table 74. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Application (2027-2032) & (US$/Unit)
Table 75. Ypsomed AG Basic Information, Manufacturing Base and Competitors
Table 76. Ypsomed AG Major Business
Table 77. Ypsomed AG Large-Volume Wearable Patch Drug Delivery Devices Product and Services
Table 78. Ypsomed AG Large-Volume Wearable Patch Drug Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Ypsomed AG Recent Developments/Updates
Table 80. Ypsomed AG Competitive Strengths & Weaknesses
Table 81. Enable Injections, Inc. Basic Information, Manufacturing Base and Competitors
Table 82. Enable Injections, Inc. Major Business
Table 83. Enable Injections, Inc. Large-Volume Wearable Patch Drug Delivery Devices Product and Services
Table 84. Enable Injections, Inc. Large-Volume Wearable Patch Drug Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Enable Injections, Inc. Recent Developments/Updates
Table 86. Enable Injections, Inc. Competitive Strengths & Weaknesses
Table 87. West Pharmaceutical Services, Inc. Basic Information, Manufacturing Base and Competitors
Table 88. West Pharmaceutical Services, Inc. Major Business
Table 89. West Pharmaceutical Services, Inc. Large-Volume Wearable Patch Drug Delivery Devices Product and Services
Table 90. West Pharmaceutical Services, Inc. Large-Volume Wearable Patch Drug Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. West Pharmaceutical Services, Inc. Recent Developments/Updates
Table 92. West Pharmaceutical Services, Inc. Competitive Strengths & Weaknesses
Table 93. Becton, Dickinson and Company Basic Information, Manufacturing Base and Competitors
Table 94. Becton, Dickinson and Company Major Business
Table 95. Becton, Dickinson and Company Large-Volume Wearable Patch Drug Delivery Devices Product and Services
Table 96. Becton, Dickinson and Company Large-Volume Wearable Patch Drug Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. Becton, Dickinson and Company Recent Developments/Updates
Table 98. Becton, Dickinson and Company Competitive Strengths & Weaknesses
Table 99. LTS Lohmann Therapie-Systeme AG Basic Information, Manufacturing Base and Competitors
Table 100. LTS Lohmann Therapie-Systeme AG Major Business
Table 101. LTS Lohmann Therapie-Systeme AG Large-Volume Wearable Patch Drug Delivery Devices Product and Services
Table 102. LTS Lohmann Therapie-Systeme AG Large-Volume Wearable Patch Drug Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. LTS Lohmann Therapie-Systeme AG Recent Developments/Updates
Table 104. LTS Lohmann Therapie-Systeme AG Competitive Strengths & Weaknesses
Table 105. Gerresheimer AG Basic Information, Manufacturing Base and Competitors
Table 106. Gerresheimer AG Major Business
Table 107. Gerresheimer AG Large-Volume Wearable Patch Drug Delivery Devices Product and Services
Table 108. Gerresheimer AG Large-Volume Wearable Patch Drug Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Gerresheimer AG Recent Developments/Updates
Table 110. Gerresheimer AG Competitive Strengths & Weaknesses
Table 111. Nemera Basic Information, Manufacturing Base and Competitors
Table 112. Nemera Major Business
Table 113. Nemera Large-Volume Wearable Patch Drug Delivery Devices Product and Services
Table 114. Nemera Large-Volume Wearable Patch Drug Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Nemera Recent Developments/Updates
Table 116. Nemera Competitive Strengths & Weaknesses
Table 117. Stevanato Group S.p.A. Basic Information, Manufacturing Base and Competitors
Table 118. Stevanato Group S.p.A. Major Business
Table 119. Stevanato Group S.p.A. Large-Volume Wearable Patch Drug Delivery Devices Product and Services
Table 120. Stevanato Group S.p.A. Large-Volume Wearable Patch Drug Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Stevanato Group S.p.A. Recent Developments/Updates
Table 122. Stevanato Group S.p.A. Competitive Strengths & Weaknesses
Table 123. Elcam Drug Delivery Devices Basic Information, Manufacturing Base and Competitors
Table 124. Elcam Drug Delivery Devices Major Business
Table 125. Elcam Drug Delivery Devices Large-Volume Wearable Patch Drug Delivery Devices Product and Services
Table 126. Elcam Drug Delivery Devices Large-Volume Wearable Patch Drug Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 127. Elcam Drug Delivery Devices Recent Developments/Updates
Table 128. Elcam Drug Delivery Devices Competitive Strengths & Weaknesses
Table 129. CC Biotechnology Corporation Basic Information, Manufacturing Base and Competitors
Table 130. CC Biotechnology Corporation Major Business
Table 131. CC Biotechnology Corporation Large-Volume Wearable Patch Drug Delivery Devices Product and Services
Table 132. CC Biotechnology Corporation Large-Volume Wearable Patch Drug Delivery Devices Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 133. CC Biotechnology Corporation Recent Developments/Updates
Table 134. CC Biotechnology Corporation Competitive Strengths & Weaknesses
Table 135. Global Key Players of Large-Volume Wearable Patch Drug Delivery Devices Upstream (Raw Materials)
Table 136. Global Large-Volume Wearable Patch Drug Delivery Devices Typical Customers
Table 137. Large-Volume Wearable Patch Drug Delivery Devices Typical Distributors
LIST OF FIGURES
Figure 1. Large-Volume Wearable Patch Drug Delivery Devices Picture
Figure 2. World Large-Volume Wearable Patch Drug Delivery Devices Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Large-Volume Wearable Patch Drug Delivery Devices Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2032) & (K Units)
Figure 5. World Large-Volume Wearable Patch Drug Delivery Devices Average Price (2021-2032) & (US$/Unit)
Figure 6. World Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share by Region (2021-2032)
Figure 7. World Large-Volume Wearable Patch Drug Delivery Devices Production Market Share by Region (2021-2032)
Figure 8. North America Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2032) & (K Units)
Figure 9. Europe Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2032) & (K Units)
Figure 10. China Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2032) & (K Units)
Figure 11. Japan Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2032) & (K Units)
Figure 12. Large-Volume Wearable Patch Drug Delivery Devices Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032) & (K Units)
Figure 15. World Large-Volume Wearable Patch Drug Delivery Devices Consumption Market Share by Region (2021-2032)
Figure 16. United States Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032) & (K Units)
Figure 17. China Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032) & (K Units)
Figure 18. Europe Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032) & (K Units)
Figure 19. Japan Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032) & (K Units)
Figure 20. South Korea Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032) & (K Units)
Figure 22. India Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Large-Volume Wearable Patch Drug Delivery Devices by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Large-Volume Wearable Patch Drug Delivery Devices Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Large-Volume Wearable Patch Drug Delivery Devices Markets in 2025
Figure 26. United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Market Share 2025
Figure 30. China Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Market Share 2025
Figure 32. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share by Type in 2025
Figure 34. Fully Disposable Patch Delivery Device
Figure 35. Reusable Controller Patch Delivery Device
Figure 36. Other
Figure 37. World Large-Volume Wearable Patch Drug Delivery Devices Production Market Share by Type (2021-2032)
Figure 38. World Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share by Type (2021-2032)
Figure 39. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Drive Mechanism, (USD Million), 2021 & 2025 & 2032
Figure 41. World Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share by Drive Mechanism in 2025
Figure 42. Low Volume Patch Delivery Device
Figure 43. Medium Volume Patch Delivery Device
Figure 44. High Volume Patch Delivery Device
Figure 45. Other
Figure 46. World Large-Volume Wearable Patch Drug Delivery Devices Production Market Share by Drive Mechanism (2021-2032)
Figure 47. World Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share by Drive Mechanism (2021-2032)
Figure 48. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Drive Mechanism (2021-2032) & (US$/Unit)
Figure 49. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Drug Loading Configuration, (USD Million), 2021 & 2025 & 2032
Figure 50. World Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share by Drug Loading Configuration in 2025
Figure 51. Mechanical Drive Patch Delivery Device
Figure 52. Electromechanical Drive Patch Delivery Device
Figure 53. Micropump Drive Patch Delivery Device
Figure 54. Magnetic Coupling Drive Patch Delivery Device
Figure 55. Other
Figure 56. World Large-Volume Wearable Patch Drug Delivery Devices Production Market Share by Drug Loading Configuration (2021-2032)
Figure 57. World Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share by Drug Loading Configuration (2021-2032)
Figure 58. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Drug Loading Configuration (2021-2032) & (US$/Unit)
Figure 59. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 60. World Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share by Application in 2025
Figure 61. Large Molecule Biologic Delivery
Figure 62. Small Molecule Injectable Delivery
Figure 63. Other
Figure 64. World Large-Volume Wearable Patch Drug Delivery Devices Production Market Share by Application (2021-2032)
Figure 65. World Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share by Application (2021-2032)
Figure 66. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Application (2021-2032) & (US$/Unit)
Figure 67. Large-Volume Wearable Patch Drug Delivery Devices Industry Chain
Figure 68. Large-Volume Wearable Patch Drug Delivery Devices Procurement Model
Figure 69. Large-Volume Wearable Patch Drug Delivery Devices Sales Model
Figure 70. Large-Volume Wearable Patch Drug Delivery Devices Sales Channels, Direct Sales, and Distribution
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Large-Volume Wearable Patch Drug Delivery Devices Picture
Figure 2. World Large-Volume Wearable Patch Drug Delivery Devices Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Large-Volume Wearable Patch Drug Delivery Devices Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2032) & (K Units)
Figure 5. World Large-Volume Wearable Patch Drug Delivery Devices Average Price (2021-2032) & (US$/Unit)
Figure 6. World Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share by Region (2021-2032)
Figure 7. World Large-Volume Wearable Patch Drug Delivery Devices Production Market Share by Region (2021-2032)
Figure 8. North America Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2032) & (K Units)
Figure 9. Europe Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2032) & (K Units)
Figure 10. China Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2032) & (K Units)
Figure 11. Japan Large-Volume Wearable Patch Drug Delivery Devices Production (2021-2032) & (K Units)
Figure 12. Large-Volume Wearable Patch Drug Delivery Devices Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032) & (K Units)
Figure 15. World Large-Volume Wearable Patch Drug Delivery Devices Consumption Market Share by Region (2021-2032)
Figure 16. United States Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032) & (K Units)
Figure 17. China Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032) & (K Units)
Figure 18. Europe Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032) & (K Units)
Figure 19. Japan Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032) & (K Units)
Figure 20. South Korea Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032) & (K Units)
Figure 21. ASEAN Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032) & (K Units)
Figure 22. India Large-Volume Wearable Patch Drug Delivery Devices Consumption (2021-2032) & (K Units)
Figure 23. Producer Shipments of Large-Volume Wearable Patch Drug Delivery Devices by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 24. Global Four-firm Concentration Ratios (CR4) for Large-Volume Wearable Patch Drug Delivery Devices Markets in 2025
Figure 25. Global Four-firm Concentration Ratios (CR8) for Large-Volume Wearable Patch Drug Delivery Devices Markets in 2025
Figure 26. United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 27. United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Production Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Large-Volume Wearable Patch Drug Delivery Devices Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Market Share 2025
Figure 30. China Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Market Share 2025
Figure 31. Rest of World Based Manufacturers Large-Volume Wearable Patch Drug Delivery Devices Production Market Share 2025
Figure 32. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 33. World Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share by Type in 2025
Figure 34. Fully Disposable Patch Delivery Device
Figure 35. Reusable Controller Patch Delivery Device
Figure 36. Other
Figure 37. World Large-Volume Wearable Patch Drug Delivery Devices Production Market Share by Type (2021-2032)
Figure 38. World Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share by Type (2021-2032)
Figure 39. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Type (2021-2032) & (US$/Unit)
Figure 40. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Drive Mechanism, (USD Million), 2021 & 2025 & 2032
Figure 41. World Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share by Drive Mechanism in 2025
Figure 42. Low Volume Patch Delivery Device
Figure 43. Medium Volume Patch Delivery Device
Figure 44. High Volume Patch Delivery Device
Figure 45. Other
Figure 46. World Large-Volume Wearable Patch Drug Delivery Devices Production Market Share by Drive Mechanism (2021-2032)
Figure 47. World Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share by Drive Mechanism (2021-2032)
Figure 48. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Drive Mechanism (2021-2032) & (US$/Unit)
Figure 49. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Drug Loading Configuration, (USD Million), 2021 & 2025 & 2032
Figure 50. World Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share by Drug Loading Configuration in 2025
Figure 51. Mechanical Drive Patch Delivery Device
Figure 52. Electromechanical Drive Patch Delivery Device
Figure 53. Micropump Drive Patch Delivery Device
Figure 54. Magnetic Coupling Drive Patch Delivery Device
Figure 55. Other
Figure 56. World Large-Volume Wearable Patch Drug Delivery Devices Production Market Share by Drug Loading Configuration (2021-2032)
Figure 57. World Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share by Drug Loading Configuration (2021-2032)
Figure 58. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Drug Loading Configuration (2021-2032) & (US$/Unit)
Figure 59. World Large-Volume Wearable Patch Drug Delivery Devices Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 60. World Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share by Application in 2025
Figure 61. Large Molecule Biologic Delivery
Figure 62. Small Molecule Injectable Delivery
Figure 63. Other
Figure 64. World Large-Volume Wearable Patch Drug Delivery Devices Production Market Share by Application (2021-2032)
Figure 65. World Large-Volume Wearable Patch Drug Delivery Devices Production Value Market Share by Application (2021-2032)
Figure 66. World Large-Volume Wearable Patch Drug Delivery Devices Average Price by Application (2021-2032) & (US$/Unit)
Figure 67. Large-Volume Wearable Patch Drug Delivery Devices Industry Chain
Figure 68. Large-Volume Wearable Patch Drug Delivery Devices Procurement Model
Figure 69. Large-Volume Wearable Patch Drug Delivery Devices Sales Model
Figure 70. Large-Volume Wearable Patch Drug Delivery Devices Sales Channels, Direct Sales, and Distribution
Figure 71. Methodology
Figure 72. Research Process and Data Source
